glucose + magnesium chloride hexahydrate + potassium chloride + sodium acetate trihydrate + sodium chloride + sodium gluconate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
glucose + magnesium chloride hexahydrate + potassium chloride + sodium acetate trihydrate + sodium chloride + sodium gluconate: clinical details
Prescribing considerations
- Assess fluid, electrolyte, glucose and acid–base requirements before selection.
- Use particular caution with cardiac, pulmonary or renal impairment, diabetes, hyperosmolar states, hypocalcaemia, myasthenia gravis, head injury or conditions causing sodium retention.
- It is not intended as primary treatment for severe metabolic acidosis, severe potassium deficiency or hypomagnesaemia.
- Account for the risk of fluid overload, hyperglycaemia, hyperkalaemia, hyponatraemia and metabolic alkalosis.
- A positive Bio-Rad Platelia Aspergillus EIA result may be false positive and requires confirmation.
Contraindications and cautions
- Hyperkalaemia
- Renal failure
- Heart block
- Metabolic or respiratory alkalosis
- Hypochlorhydria
- Uncompensated diabetes or other known glucose intolerance
- Hyperosmolar coma, hyperglycaemia or hyperlactataemia
- Hypersensitivity to an active substance or excipient
Monitoring
- Clinical fluid balance and signs of overhydration
- Blood glucose
- Serum and, where appropriate, urine electrolytes
- Acid–base status
- Infusion site and delivery equipment
- Closer glucose and electrolyte surveillance in neonates and children
Clinical pharmacology
A hyperosmotic electrolyte-and-glucose solution that expands extracellular fluid. Glucose provides carbohydrate, while acetate and gluconate are metabolised to bicarbonate and contribute an alkalinising effect.
Formulation and product differences
- The formulation contains glucose, sodium, potassium, magnesium, chloride, acetate and gluconate.
- It is hyperosmotic and should not be administered through a peripheral vein.
- It contains no calcium.
- It is supplied as a clear, single-use solution; partially used bags must not be reconnected.
- Compatibility and stability must be established before adding another medicine, and solutions containing additives should generally be used immediately.
glucose + magnesium chloride hexahydrate + potassium chloride + sodium acetate trihydrate + sodium chloride + sodium gluconate interactions
The clinical team should review all medicines because the solution contains glucose, potassium, magnesium, sodium, acetate and gluconate.
Potassium-sparing diuretics
Amiloride, spironolactone, triamterene and related medicines can substantially increase the risk of hyperkalaemia.
ACE inhibitors, angiotensin-II receptor blockers, tacrolimus or ciclosporin
Concurrent use can increase blood potassium, especially when kidney function is impaired.
Medicines associated with hyponatraemia
Diuretics, NSAIDs, SSRIs, antipsychotics, opioids, antiepileptics, oxytocin and some chemotherapy may increase the risk of low sodium.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.